Detalles de la búsqueda
1.
Meta-analysis of individual patient safety data from six randomized, placebo-controlled trials with the antiangiogenic VEGFR2-binding monoclonal antibody ramucirumab.
Ann Oncol
; 28(12): 2932-2942, 2017 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28950290
2.
Correlation between treatment effects on response rate and progression-free survival and overall survival in trials of targeted therapies in molecularly enriched populations.
ESMO Open
; 7(2): 100398, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35183043
3.
Indicators of lifetime estrogen exposure: effect on breast cancer incidence and interaction with raloxifene therapy in the multiple outcomes of raloxifene evaluation study participants.
J Clin Oncol
; 19(12): 3111-6, 2001 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-11408508
4.
Effects of raloxifene and hormone replacement therapy on markers of serum atherogenicity in healthy postmenopausal women.
Maturitas
; 39(1): 71-7, 2001 Jul 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-11451623
5.
Role of tumor necrosis factor-alpha and interleukin-6 in the effects of hormone replacement therapy and raloxifene on C-reactive protein in postmenopausal women.
Am J Cardiol
; 88(7): 825-8, 2001 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-11589863
6.
Application of a generalized random effects regression model for cluster-correlated longitudinal data to a school-based smoking prevention trial.
Am J Epidemiol
; 152(12): 1192-200, 2000 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-11130626
Resultados
1 -
6
de 6
1
Próxima >
>>